The New Diagnostic Paradigms in Follicular Patterned Lesions of the Thyroid and Effects on Reporting of Thyroid Fine-Needle Aspiration Specimens

Zubair W. Baloch, MD, PhD
Professor of Pathology &
Laboratory Medicine
UPENN Medical Center
Perelman School of Medicine
Philadelphia, Pennsylvania

It has been proposed to classify the non-invasive follicular variant of papillary thyroid carcinoma (FVPTC) as “non-invasive follicular thyroid neoplasm with papillary like nuclear features” (NIFT-P). No doubt this change in the name i.e. not calling FVPTC as “carcinoma” can lead to much confusion or add to it. This presentation will discuss the current diagnostic criteria for the follicular patterned lesions of the thyroid and the impact of this reclassification of FVPTC as “not carcinoma” on the reporting of thyroid FNA specimens.

Target Audience

This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.

Learning Objectives

  • Discuss the current diagnostic criteria of follicular patterned lesions of the thyroid
  • Understand the new classification of non-invasive follicular patterned thyroid lesions
  • Understand the potential changes in the reporting of thyroid FNA specimens
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 1.00 California Credits
  • 2.00 CMLE
  • 2.00 Florida Credits
  • 2.00 MOC II
  • 2.00 Participant
Course opens: 
03/28/2017
Course expires: 
03/28/2020
Cost:
$105.00

Zubair W. Baloch, MD, PhD
Professor of Pathology & Laboratory Medicine
UPENN Medical Center
Perelman School of Medicine
Philadelphia, Pennsylvania

Current ACCME guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Therefore, it is the policy of the ASC to insure balance, independence, objectivity, and scientific rigor in all its educational programs.  All planning individuals participating in any ASC Educational Activity are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program.  Click here for a complete list.

Presenter
Zubair W. Baloch, MD, PhD

Disclosure
The presenter has no conflicts of interest or financial relationships to disclose.

 

ACCREDITATION AND DESIGNATION STATEMENTS

Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

American Board of Pathology Maintenance of Certification (MOC)
This product can help fulfill the CME requirements and Self-Assessment Modules (SAMs) mandated by the American Board of Pathology Maintenance of Certification (MOC) process.  Earn up to 2.0 SAM Credit Hours.

Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians.  The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 1.00 California Credits
  • 2.00 CMLE
  • 2.00 Florida Credits
  • 2.00 MOC II
  • 2.00 Participant

Price

Cost:
$105.00
Please login or register to take this course.